$FibroGen (FGEN.US)$
News: Fibrogen announced that the new clinical drug application for FG-3165, a monoclonal antibody targeting Galectin-9, has been approved by the FDA for treating solid tumors.

$LuxUrban Hotels (LUXH.US)$ Stock dilution...

$FibroGen (FGEN.US)$
FibroGen Announces Clinical Trial Supply Agreement With Regeneron Pharmaceuticals to Evaluate Fibrogen’s Immuno-Oncology Assets, FG-3165 (Anti-Galectin 9) and FG-3175 (Anti-Ccr8), in Combination With Libtayo® in Upcoming Clinical Trials

$Greenwave Technology Solutions (GWAV.US)$
I will hold

$Greenwave Technology Solutions (GWAV.US)$
go to
$AgriFORCE Growing (AGRI.US)$